Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
US11472861B2 · kind B2 · utility
3Cited by
67References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2021 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Dec 21, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2030/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.